Crossref
Cytisinicline More Than Doubled Chances of Quitting E-Cigarettes
JAMA · 2024
DOI: 10.1001/jama.2024.9646 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Smoking Cessation, Vaping, Smoking Cessation Agents, Nicotinic Agonists.
Abstract (Originalsprache)
Nancy A. Rigotti, MD; Neal L. Benowitz, MD; Judith J. Prochaska, PhD, MPH; Daniel F. Cain, BSc; Julie Ball, MS; Anthony Clarke, PhD; Brent A. Blumenstein, PhD; Cindy Jacobs, PhD, MD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Smoking CessationVapingSmoking Cessation AgentsNicotinic AgonistsHumansElectronic Nicotine Delivery SystemsUnited StatesRandomized Controlled Trials as TopicAdultReceptors, Nicotinic
Substanzen
Receptors, NicotinicSmoking Cessation AgentsNicotinic Agonists
Zitieren
APA
Harris, E. (2024). Cytisinicline More Than Doubled Chances of Quitting E-Cigarettes. JAMA. https://doi.org/10.1001/jama.2024.9646
Vancouver
Harris E. Cytisinicline More Than Doubled Chances of Quitting E-Cigarettes. JAMA. 2024. doi:10.1001/jama.2024.9646
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Cytisinicline More Than Doubled Chances of Quitting E-Cigarettes},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.9646}
}
EUVIMED